Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 16

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

335

HTML

2375

Tables (1-6)

189

Sum=2899

Apr 28, 2005 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Apr 28, 2005; 11(16): 2462-2466
Published online Apr 28, 2005. doi: 10.3748/wjg.v11.i16.2462

Table 1 Distribution of age and course of the illness.

Age and course		2000s group n (%)	1990s group n (%)
Age (yr)	<30	21 (17.2)	19 (17.9)
	30-	31 (25.4)	33 (31.1)
	40-	39 (32.0)	21 (19.8)
	50-	14 (11.5)	21 (19.8)
	60-	17 (13.9)	12 (11.3)
Total course of the illness (yr)	<1.0	61 (50.0)^a	33 (31.7)
	1.0-	48 (39.3)	40 (37.7)
	5.0-	6 (4.9)^a	18 (17.0)
	10.0-	7 (5.7)^a	15 (17.0)
Course of present
flare-up (yr)	<0.5	85 (69.7)	71 (67.0)
	0.5-	20 (16.4)	17 (16.0)
	1.0-	17 (13.9)	18 (17.0)

^aP<0.05 vs 1990s group.

Citation: Chen QK, Yuan SZ, Wen ZF, Zhong YQ, Li CJ, Wu HS, Mai CR, Xie PY, Lu YM, Yu ZL. Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis. World J Gastroenterol 2005; 11(16): 2462-2466
URL: https://www.wjgnet.com/1007-9327/full/v11/i16/2462.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i16.2462